Ipramol - Ipratropium bromide with salbutamol
Teva
Description
Antimuscarinic bronchodilator with short-acting selective beta2 agonists.
• Adult and child over 12 years for bronchospasm in chronic obstructive pulmonary disease: by inhalation of nebulised solution, 0.5/2.5 mg, 3–4 times daily.
Indications
For the treatment of bronchospasm in COPD.
Preparations Available
Nebuliser liquid
Sizes Available
Nebuliser liquid
Ipramol 0.5/2.5 mg, 2.5 ml, 60 vials
More on: Bronchodilators , Compound preparations